Re-Vana Therapeutics
Wenrui has a B.Sc in Pharmacy (Huazhong University of Science and Technology, China) and an MS degree in pharmaceutical analysis (Queen’s University Belfast, UK); he is completing his Ph.D thesis in Ocular Drug Delivery. Wenrui has research experience in developing pharmaceutical formulations as ocular inserts for the controlled/sustained release of small molecule drugs and extensive knowledge in various imaging techniques, cell-based assays, protein analytical methods, bioactivity determination, and biocompatibility assays.
He has developed and characterized the formulation of electrospun inserts which provide sustained delivery to the anterior segment of the eye with good mucoadhesive properties.
Re-Vana Therapeutics
Re-Vana Therapeutics is an ocular pharmaceutical and drug delivery company focused on the development and commercialisation of revolutionary long-acting biodegradable drug delivery platforms to treat chronic eye diseases such as age-related macular degeneration, diabetic retinopathy, glaucoma and ocular infections.